A statistical analysis and cytohistologic correlation of fine needle aspiration cytology in lesions of male breast

---

Original Article

Author Details : Kulwant Singh, Roque G. Wiseman Pinto

Volume : 2, Issue : 4, Year : 2015

Article Page : 215-218

Suggest article by email

Get Permission

---

Abstract

Background and Objectives: Fine needle aspiration cytology is a widely used first line investigation for breast lesions in surgical practice. Gynecomastia is the most common lesion of male breast. FNAC is usually asked for male breast lesions in case of unilateral breast enlargement to rule out malignancy. This study was done to obtain sensitivity, specificity, other statistical parameters and cytohistological correlation in FNAC of male breast lesions so as to know its diagnostic utility.
Methods: Study was performed at Goa medical college over a period of seven years. Only the cases with availability of histological diagnosis were included in the study. All slides were stained with Hematoxylin and eosin after fixation in alcohol-ether mixture. Results: Sensitivity, specificity, accuracy, positive predictive value and negative predictive value were 100% for FNAC of male breast lesions. Excellent cytohistologic correlation was also observed.
Conclusion: These results indicate that FNAC of male breast lesions shows excellent specificity, sensitivity and cytohistologic correlation. Hence, it can be used in initial diagnostic workup of lesions of male breast.

Keywords: Fine needle aspiration cytology, Male Breast lesions, Statistical analysis

How to cite : Singh K, Pinto R G W, A statistical analysis and cytohistologic correlation of fine needle aspiration cytology in lesions of male breast. Indian J Pathol Oncol 2015;2(4):215-218

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.